Acquisition Opportunity Optimal Research is now positioned under Accelerated Enrollment Solutions (AES) as of 2019, suggesting a sales route through AES for clinical trial acceleration services and site/enrollment solutions to sponsors seeking faster timelines and budget certainty.

Strategic Fit As part of a larger network via the Synexus acquisition, there is an opportunity to align Optimal’s dedicated research sites with broader multinational trial programs, appealing to sponsors needing scalable site networks and specialist laboratory services.

Tech & Data Active digital stack including Google Analytics, Tag Manager, HubSpot and tracking pixels indicates readiness for data-driven marketing, analytics for site performance, and lead nurturing to optimize sponsor engagement and conversion.

Market Positioning Small to mid-size scale (51-200 employees) with a revenue range of one to several million positions Optimal as a cost-effective entry point for sponsors piloting multi-site studies or trials requiring focused specialist sites within a global network.

Growth Alignment Historical acquisition by Synexus and alignment with AES signals potential for cross-sell of enrollment and site services to large pharma and CROs, presenting opportunities for bundled offerings and faster trial start-up across the sponsor portfolio.